Robert N Jennings, Jr

Title: Innovations of Robert N Jennings, Jr.

Introduction

Robert N Jennings, Jr. is an accomplished inventor based in San Jose, CA (US). He has made significant contributions to the field of controlled release drug delivery systems. With a total of 2 patents, Jennings has focused on developing innovative hydrogel compositions and methods for the administration of growth factors.

Latest Patents

His latest patents include "Hydrogel compositions for the controlled release administration of growth factors." This invention discloses compositions and methods for the controlled release delivery of polypeptide growth factors. The hydrogels comprise a polypeptide growth factor with at least one region of positive charge, a physiologically acceptable water-miscible anionic polymer, a non-ionic polymeric viscosity controlling agent, and water. Another notable patent is "Controlled release delivery of peptide or protein." This invention involves compositions and devices for the controlled release delivery of peptide or protein drugs. It is produced by dispersing a glassy matrix phase containing the drug and a thermoprotectant in a bioerodable, biocompatible polymer.

Career Highlights

Robert N Jennings, Jr. is currently associated with Scios Inc., where he continues to innovate in the field of drug delivery systems. His work has the potential to significantly impact therapeutic applications, particularly in the local delivery of angiogenic factors.

Collaborations

He has collaborated with notable coworkers such as Yu-Chang John Wang and Bing Yang, contributing to advancements in their shared field of research.

Conclusion

Robert N Jennings, Jr. exemplifies the spirit of innovation through his patents and contributions to drug delivery technology. His work continues to pave the way for advancements in medical treatments.